Unlike other hemophilia therapies, Qfitlia is indicated for both hemophilia A and B, and can be given in patients regardless ...

Equities researchers at William Blair issued their FY2028 earnings estimates for Tempest Therapeutics in a research report ...

Shares of AI software company Palantir Technologies (PLTR) fell today, even after investment firm William Blair said that the ...

Stock analysts at William Blair issued their Q1 2025 EPS estimates for Neurogene in a research report issued to clients and ...

William Blair analyst Louie DiPalma says the U.S. Army changed course and put the Army Data Platform 2.0 program on indefinite hold. In 2023, ...

Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...

Fintel reports that on March 26, 2025, William Blair initiated coverage of StoneX Group (NasdaqGS:SNEX) with a Outperform ...

Tesla shares fell more than 5% on Wednesday, ending the EV maker's blistering rebound out of a prolonged slump.

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The leading factor in the rating is the stability of the management team. Specifically, the fund has not seen a manager ...

Lululemon stock fell 15% in afternoon trading after CEO Calvin McDonald said consumers are beginning to spend less in ...

Emerging markets present a landscape of opportunity for equity investors despite macroeconomic headwinds. Click to read.